Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation
Authors:
- Milena PetkovaMPMilena Petkova
- Marle KraftMKMarle Kraft
- Simon StrittSSSimon Stritt
- Ines Martinez-CorralIMInes Martinez-Corral
- Henrik OrtsäterHOHenrik Ortsäter
- Michael VanlandewijckMVMichael Vanlandewijck
- Bojana JakicBJBojana Jakic
- Eulàlia BaselgaEBEulàlia Baselga
- Sandra D. CastilloSCSandra D. Castillo
- Mariona GrauperaMGMariona Graupera
- Christer BetsholtzCBChrister Betsholtz
- Taija MäkinenTMTaija Mäkinen
Top Cited Papers
Open Access
- 23 January 2023
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 220 (4)
Abstract
Oncogenic mutations in PIK3CA, encoding p110α-PI3K, are a common cause of venous and lymphatic malformations. Vessel type–specific disease pathogenesis is poorly understood, hampering development of efficient therapies. Here, we reveal a new immune-interacting subtype of Ptx3-positive dermal lymphatic capillary endothelial cells (iLECs) that recruit pro-lymphangiogenic macrophages to promote progressive lymphatic overgrowth. Mouse model of Pik3caH1047R-driven vascular malformations showed that proliferation was induced in both venous and lymphatic ECs but sustained selectively in LECs of advanced lesions. Single-cell transcriptomics identified the iLEC population, residing at lymphatic capillary terminals of normal vasculature, that was expanded in Pik3caH1047R mice. Expression of pro-inflammatory genes, including monocyte/macrophage chemokine Ccl2, in Pik3caH1047R-iLECs was associated with recruitment of VEGF-C–producing macrophages. Macrophage depletion, CCL2 blockade, or anti-inflammatory COX-2 inhibition limited Pik3caH1047R-driven lymphangiogenesis. Thus, targeting the paracrine crosstalk involving iLECs and macrophages provides a new therapeutic opportunity for lymphatic malformations. Identification of iLECs further indicates that peripheral lymphatic vessels not only respond to but also actively orchestrate inflammatory processes.Keywords
All Related Versions
Funding Information
- Swedish Research Council (2018-05973, 2020-0269)
- Knut and Alice Wallenberg Foundation (2018.0218, 2020.0057)
- Göran Gustafsson Stiftelser
- Swedish Cancer Society (19 0220 Pj, 19 0219 Us)
- European Research Council (ERC-2014-CoG-646849)
- H2020 Marie Skłodowska-Curie Actions (814316, 749731)
- La Caixa Foundation (HR18-00120)
- la Caixa Banking Foundation (LCF/BQ/PR20/11770002)
- Deutsche Forschungsgemeinschaft (STR 1538/1-1)
- European Molecular Biology Organization (ALTF 86-2017)
This publication has 82 references indexed in Scilit:
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsGenome Biology, 2013
- Neuropilin-2 and vascular endothelial growth factor receptor-3 are up-regulated in human vascular malformationsAngiogenesis, 2012
- Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesisVascular Cell, 2012
- Developmental timing of CCM2 loss influences cerebral cavernous malformations in miceJournal of Experimental Medicine, 2011
- Tertiary Lymphoid Organs in Lymphatic MalformationsLymphatic Research and Biology, 2011
- An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammationBlood, 2010
- A robust and high-throughput Cre reporting and characterization system for the whole mouse brainNature Neuroscience, 2009
- Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasiaJournal of Clinical Investigation, 2009
- Low Levels of Tumor Necrosis Factor α Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor SiteCancer Research, 2008
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005